All News
Filter News
Found 64,949 articles
-
Next Generation Nebulizers Market - Key Challenges and Winning Imperatives Report
6/18/2020
The growing need for state-of-the-art drug delivery mechanisms is the prime component that’s creating ripples across the next generation nebulizers market across the forecast period of 2019-2027.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 17, 2020.
-
Numerous biopharma companies are testing or working to develop drugs and vaccines. But what is a bit unusual is the number of staffers at biotech and pharma companies and health care involved as participants in studies and clinical trials.
-
Researchers found that certain individuals who have never been exposed to COVID-19 appear to have “helper” T cells that are capable of recognizing and responding to the virus.
-
The race toward a COVID-19 vaccine is focused around scientific development right now, but companies also need to be planning for manufacturing.
-
Enrollment in Phase 2 Clinical Trial in Cystic Fibrosis Has Been Resumed in Israel and Europe After Being Paused Temporarily in Response to the COVID-19 Pandemic
6/17/2020
Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that enrollment in its Phase 2 clinical trial for ELX-02 i
-
Scientific partnership including Frederick National Laboratory develops highly specific test to detect antibodies to COVID-19
6/17/2020
Scientists at the Frederick National Laboratory for Cancer Research and investigators across the National Institutes of Health (NIH) have developed a highly specific serology test to determine whether a person has antibodies to SARS-CoV-2, a vital tool to understanding the spread of infection from the virus that causes COVID-19.
-
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
6/17/2020
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today highlighted new external research demonstrating the involvement of Neuropilin biology in SARS-CoV-2 infection.
-
Novomer to Probe Functional Beta-Lactones to Enhance Virus Deactivation
6/17/2020
Novomer, Inc., the leading developer of beta-propiolactones and derivatives, is targeting novel functionalized beta-propiolactones for possible use in vaccine applications against coronaviruses, including SARS-CoV-2 (the coronavirus causing the COVID-19 disease).
-
Aurora Spine Postpones and Reschedules Annual Meeting of Shareholders
6/17/2020
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced today that given the extraordinary circumstances of the ongoing COVID-19 pandemic and the resulting restrictions on public gatherings, it is postponing its annual meeting of shareholders to August 11, 2020 in Toronto, Canada.
-
Ascend Collaborates on Research to Estimate the Exposure to SARS-CoV-2 Among the U.S. Dialysis Population
6/17/2020
Ascend, the nation's leading dialysis testing laboratory, collaborates with the Stanford University School of Medicine to study the prevalence of SARS-CoV-2 antibodies in a nationwide sample of dialysis patients.
-
IDEAYA Announces Pricing of Public Offering of Common Stock
6/17/2020
IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions.
-
BioLabs LA at The Lundquist Institute Celebrates 1 Year of Innovation with 20 In-House Startup Companies
6/17/2020
State-of-the-art lab and office space is home to biotech companies that have raised more than $31 million
-
Verdosome Introduces Saliva Test for COVID-19
6/17/2020
Colorado-headquartered small business offers saliva-based testing for SARS-CoV-2, the virus that causes COVID-19
-
CORAT Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program
6/17/2020
YUMAB GmbH previously announced it identified fully human monoclonal antibodies with neutralizing activity against live coronavirus strain SARS-CoV-2. The company deployed its advanced antibody discovery platform to r
-
BioMarin Provides Additional Data from Recent 4 Year Update of Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in Late-Breaking Oral Presentation at World Federation of Hemophilia Virtual Summit
6/17/2020
96% Mean Reduction in Factor VIII Usage Greater than 90% Reduction in Bleeding Episodes, Cumulative Mean Annualized Bleeding Rates Remain Less than One (1) Webinar with BioMarin Management and Study Investigators, Professor John Pasi and Dr. Steve Pipe Today at 5:00 PM ET [17-June-2020] SAN RAFAEL, Calif. , June 17, 2020 /PRNewswire/ -- BioMarin Ph
-
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
6/17/2020
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibi
-
Nascent Biotech to Begin Animal Model Studies for Pritumumab Against Coronaviruses and COVID-19
6/17/2020
Nascent Biotech, Inc. (OTCQB: NBIO) , today announced after receiving early In-Vitro study results Pritumumab, (PTB), will be advanced to laboratory-based animal studies. Nascent founder and Advisory Board Chairman Dr. Mark Glassy commented, “The laboratory results were consistent with our Brain Cancer in vitro studies and this is the next step in investigational development of PTB as potential use with COVID-19 and related Viral Infections.” An
-
BARDA and Ortho Collaborate to Advance Development of High Specificity SARS-CoV-2 Antibody Tests
6/17/2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it is collaborating with Biomedical Advanced Research and Development Authority ( BARDA ), a component of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to further advance the de
-
TransCelerate Expands COVID-19 Clinical Trial Data Sharing to Include All Biopharma Companies and BioMedical Research Institutions
6/17/2020
TransCelerate BioPharma Inc. , a non-profit collaboration comprised of 20 of the largest biopharmaceutical companies, today announced that it is expanding access to COVID-19-related patient-level clinical data sharing via DataCelerate® to non-member companies. In addition, TransCelerate will